Viewing Study NCT00079066


Ignite Creation Date: 2025-12-24 @ 4:12 PM
Ignite Modification Date: 2026-02-02 @ 6:22 PM
Study NCT ID: NCT00079066
Status: COMPLETED
Last Update Posted: 2023-08-04
First Post: 2004-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer
Sponsor: NCIC Clinical Trials Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
None Quality of Life View
Keywords:

Keywords

Keyword Brief Keyword Text View
None quality of life View
None stage IV colon cancer View
None recurrent colon cancer View
None recurrent rectal cancer View
None stage IV rectal cancer View